hh propos chang drug rebat system pbm
outlook risk
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research feb
estim
price data jan
rate updat jan
currenc amount express
methodolog valu compani
depart human servic propos
rule jan aim untangl opaqu price
incent scheme exist current rebat
system prescript drug rule attempt forc
pass-through drug manufactur discount plan
beneficiari point sale expressli exclud
safe-harbor provis antikickback statut
discount paid medicar part medicaid
managed-car organ net effect pharmaci
benefit manag econom theoret
minim face valu rebat government-
sponsor plan alreadi pass one
way anoth think bigger risk potenti
spillov privat market
today bulk rebat throughout system use
buy plan premium lower monthli payment
expens higher co-insur requir
member cost-shar arrang typic struck
manufactur gross net price
altern propos hh forc plan appli
rebat counter lower out-of-pocket requir
beneficiari trade-off higher monthli premium
expect pbm industri loudest critic
polici transit rebateless system would difficult
uncertain mani unintend consequ
associ replac nationwid price system
industri
stakehold come month perceiv
pitfal could affect variou link suppli chain
like becom clear intend
chang project fair valu estim
compani cover result propos
watch progress close better determin
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
vertic integr busi throughout almost everi
aspect pharmaceut suppli chain dynam make one
premier healthcar firm compani process
billion prescript per year approxim million health insur
member oper one largest mail-ord pharmaci own
network retail pharmaci clinic across firm
recent acquir aetna extend vertic reach
creat one power healthcar player
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
pbm face risk propos two key
reason view first adjust accept
safe harbor creat inher legal risk
oper affect addit hh explicitli
refer long-standing polici disallow price
reduct offer payer avail
medicar medicaid may hamstr
effect pbm formulari tier potenti
polici open door chang commerci
market seem rel straightforward result hh
intend defer congress regulatori author
relat privat insur wait see
pbm intend step around languag await
inquiri congression committe path
toward wide-rang chang seem rel clear
propos implement written
second along chang type discount
allow industri rule intend exclud
nonreb pbm servic fee tie list price volum
metric safe-harbor provis hh would
expressli permit flat-fe arrang attempt
better align incent among plan sponsor pbm
drug manufactur potenti magnitud chang
unclear think neg pbm profit
govern math line mani
compani space say follow
request inform topic center
medicar medicaid servic late
proactiv provid pos arrang
fulli insur member seen littl interest
pos part offer given sticker shock
higher premium express script suggest
lower price beneficiari would off-set
higher premium
payment -- conclus govern ultim seem
agre depart initi goal implement
chang effect jan think timelin
probabl optimist
polici chang like would benefit minor
sickest highest-cost patient accord hh
beneficiari enrol part would see net
reduct total drug cost nearli
popul would probabl see premium
increas greater save gener
pharmaci counter aggreg cost beneficiari
program whole would declin period
remain receiv coverag low-
incom subsidi program probabl wouldnt see much
individu would see overal benefit aggreg
spend could actual increas next decad due
higher outlay feder govern accord
propos increas direct subsidi payment
surpass save lower reinsur spend
beneficiari catastroph phase coverag lower
cost-shar requir low-incom
subsidi conclus back scenario analys
compil hh
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
